In its first year since launch, weight loss telehealth platform Calibrate raised $100 million in capital funding from investors. The series B funding round was co-led by Founders Fund and Tiger Global ...
Isabelle Kenyon’s mom had had enough. She was having weight-related health problems, and all the solutions that used to work were getting her nowhere. She told her daughter, “I’ve tried every diet and ...
Isabelle Kenyon is an alumna of investment banking, the Ivy League and the Forbes 30 Under 30. She's also the founder and CEO of Calibrate, a telehealth startup that is attempting to disrupt the $70 ...
The hits to consumer healthcare keep coming as coronavirus-induced shutdowns continue to drag on, patients delay non-essential care, and niche clinics and massive hospitals alike struggle with budget ...
Calibrate, the weight loss startup backed by Founders Fund and Tiger Global, is making changes to its management team as investors restructure the company, according to an investor letter, internal ...
NEW YORK--(BUSINESS WIRE)--Goldman Sachs (NYSE:GS) recognized Isabelle Kenyon, Founder & CEO of Calibrate, as one of the Most Exceptional Entrepreneurs of 2022 at its Builders and Innovators Summit in ...
Part of achieving those goals involves hiring, Kenyon said. The team has 170 people, and it is expected to grow to 400 by end of this year and to 800 by end of 2022, she said, adding half of those ...
Calibrate, a female-founded telehealth startup that aims to provide patients with a metabolic reset, announced Tuesday that it has raised a $22.5 million Series A round of funding. When Calibrate—the ...
Since its founding five years ago, Thirty Madison has grown to a $1 billion private valuation offering online-based treatments for chronic conditions such as hair loss and migraines. Now the NoMad ...
Calibrate, the weight loss startup backed by Founders Fund and Tiger Global, is making changes to its management team as investors restructure the company, according to an investor letter, internal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results